Local Tranexamic Acid During Vaginal Hysteractomy to Reduce Blood Loss

ConditionBlood Loss
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexFemale
Age20-90
SponsorMeir Medical Center

About this trial

Assessing the efficiency of Prophylactic use of local tranexamic acid during vaginal hysterectomy to reduce blood loss during operation

Eligibility criteria

Qualifiers

20-90 years old female patients going through vaginal hysterctomy

Disqualifiers

massive bleeding during operation due to major vessles injury

known coagulopathies

sensitivity to tranexamic acid

medical need in tranexamic acid administration during operation due to bleeding

Trial design

Treatments tested in this trial

  • local tranexamic acid injection
  • local normal saline injection to cervix

Treatment groups

60 Participants
are divided into 2 treatment groups

Sponsors and collaborators